AstraZeneca sells more than $ 1 billion stake in Moderna: The Times By Reuters

AstraZeneca sells more than $ 1 billion stake in Moderna: The Times By Reuters

by

© Reuters. The AstraZeneca office building in Brussels

(Reuters) – AstraZeneca (NASDAQ 🙂 Plc has its 7.7% stake in sales Modern (NASDAQ 🙂 Inc. for more than $ 1 billion after US biotechnology shares skyrocketed over the breakthrough of the coronavirus vaccine, reports The Times

The report added that it is not clear over what period the British AstraZeneca sold its stake in Moderna.

AstraZeneca and Moderna did not immediately respond to requests for comment.

AstraZeneca maintains a partnership with Moderna over other diseases and may in future sell its AstraZeneca / Oxford University COVID-19 vaccine on a commercial basis if the virus becomes endemic, the report said.

Moderna, whose vaccine is being cleared for emergency use against COVID-19 in the United States, said last week that it expects sales of $ 18.4 billion from its coronavirus vaccine this year.

Disclaimer: Fusion Media would like to remind you that the information on this site is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and Forex prices are not provided by stock exchanges, but rather by market makers, and therefore the prices may not be accurate and may differ from the actual market price, which means that prices are indicative and not suitable for commercial purposes. Therefore, Fusion Media is not responsible for any trading losses you may incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media accepts no liability for loss or damage resulting from reliance on the information, including data, quotes, charts and buy / sell signals contained on this website. Please be fully informed about the risks and costs associated with trading the financial markets, this is one of the riskiest forms of investment possible.

Source